These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33492046)

  • 41. Measurement of absolute myocardial blood flow in humans using dynamic cardiac SPECT and
    Shrestha U; Sciammarella M; Alhassen F; Yeghiazarians Y; Ellin J; Verdin E; Boyle A; Seo Y; Botvinick EH; Gullberg GT
    J Nucl Cardiol; 2017 Feb; 24(1):268-277. PubMed ID: 26715603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Properties of an ideal PET perfusion tracer: new PET tracer cases and data.
    Maddahi J
    J Nucl Cardiol; 2012 Feb; 19 Suppl 1():S30-7. PubMed ID: 22259007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical relevance of PET myocardial blood flow quantification.
    Leccisotti L; Lavalle M; Giordano A
    Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):338-53. PubMed ID: 27611710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Internal validation of myocardial flow reserve PET imaging using stress/rest myocardial activity ratios with Rb-82 and N-13-ammonia.
    Juneau D; Wu KY; Kaps N; Yao J; Renaud JM; Beanlands RSB; Ruddy TD; deKemp RA
    J Nucl Cardiol; 2021 Jun; 28(3):835-850. PubMed ID: 33389638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Added value of myocardial blood flow using
    Moody JB; Poitrasson-Rivière A; Hagio T; Buckley C; Weinberg RL; Corbett JR; Murthy VL; Ficaro EP
    J Nucl Cardiol; 2021 Oct; 28(5):2313-2329. PubMed ID: 32002847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging.
    Bourque JM; Hanson CA; Agostini D; Bateman TM; Bax JJ; Beanlands RSB; Berman DS; Garcia EV; Heller GV; Knuuti J; Tamaki N; Udelson JE; Maddahi J
    J Nucl Cardiol; 2021 Jun; 28(3):1105-1116. PubMed ID: 33521873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accuracy and Reproducibility of Myocardial Blood Flow Quantification by Single Photon Emission Computed Tomography Imaging in Patients With Known or Suspected Coronary Artery Disease.
    de Souza ACDAH; Harms HJ; Martell L; Bibbo C; Harrington M; Sullivan K; Hainer J; Dorbala S; Blankstein R; Taqueti VR; Foley Kijewski M; Park MA; Meretta A; Breault C; Roth N; Poitrasson-Rivière A; Soman P; Gullberg GT; Di Carli MF
    Circ Cardiovasc Imaging; 2022 Jun; 15(6):e013987. PubMed ID: 35674051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. "Apical thinning": Relations between myocardial wall thickness and apical left ventricular tracer uptake as assessed with positron emission tomography myocardial perfusion imaging.
    Steffen DA; Giannopoulos AA; Grossmann M; Messerli M; Schwyzer M; Gräni C; Gebhard C; Pazhenkottil AP; Kaufmann PA; Buechel RR
    J Nucl Cardiol; 2020 Apr; 27(2):452-460. PubMed ID: 30109592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-dose quantitative myocardial blood flow imaging using 15O-water and PET without attenuation correction.
    Lubberink M; Harms HJ; Halbmeijer R; de Haan S; Knaapen P; Lammertsma AA
    J Nucl Med; 2010 Apr; 51(4):575-80. PubMed ID: 20237035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generator-produced rubidium-82 positron emission tomography myocardial perfusion imaging-From basic aspects to clinical applications.
    Yoshinaga K; Klein R; Tamaki N
    J Cardiol; 2010 Mar; 55(2):163-73. PubMed ID: 20206068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease.
    Maddahi J; Agostini D; Bateman TM; Bax JJ; Beanlands RSB; Berman DS; Dorbala S; Garcia EV; Feldman J; Heller GV; Knuuti JM; Martinez-Clark P; Pelletier-Galarneau M; Shepple B; Tamaki N; Tranquart F; Udelson JE
    J Am Coll Cardiol; 2023 Oct; 82(16):1598-1610. PubMed ID: 37821170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of residual subtraction on myocardial blood flow and reserve estimates from rapid dynamic PET protocols.
    Poitrasson-Rivière A; Moody JB; Renaud JM; Hagio T; Arida-Moody L; Buckley C; Weinberg RL; Ficaro EP; Murthy VL
    J Nucl Cardiol; 2022 Oct; 29(5):2262-2270. PubMed ID: 34780036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extensive and balanced reduction of myocardial blood flow in patients with suspected obstructive coronary artery disease: 15O-water PET study.
    Maaniitty T; Stenström I; Saraste A; Knuuti J
    Int J Cardiol; 2021 Sep; 338():1-7. PubMed ID: 34144073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic performance of angiography-based quantitative flow ratio for the identification of myocardial ischemia as assessed by
    Strähl M; Schindler M; Keller LS; Holy E; Jakob P; Siegrist PT; Templin C; Maier W; Buechel RR; Kaufmann PA; Gebhard C; Stähli BE
    Int J Cardiol; 2020 Sep; 314():13-19. PubMed ID: 32353492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved myocardial blood flow estimation with residual activity correction and motion correction in
    Otaki Y; Van Kriekinge SD; Wei CC; Kavanagh P; Singh A; Parekh T; Di Carli M; Maddahi J; Sitek A; Buckley C; Berman DS; Slomka PJ
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1881-1893. PubMed ID: 34967914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective evaluation of Bayesian-penalized likelihood reconstruction for [
    Siekkinen R; Han C; Maaniitty T; Teräs M; Knuuti J; Saraste A; Teuho J
    J Nucl Cardiol; 2023 Aug; 30(4):1602-1612. PubMed ID: 36656496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of time-of-flight on qualitative and quantitative analyses of myocardial perfusion PET studies using (13)N-ammonia.
    Tomiyama T; Ishihara K; Suda M; Kanaya K; Sakurai M; Takahashi N; Takano H; Nitta K; Hakozaki K; Kumita S
    J Nucl Cardiol; 2015 Oct; 22(5):998-1007. PubMed ID: 25467250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantification of porcine myocardial perfusion with modified dual bolus MRI - a prospective study with a PET reference.
    Husso M; Nissi MJ; Kuivanen A; Halonen P; Tarkia M; Teuho J; Saunavaara V; Vainio P; Sipola P; Manninen H; Ylä-Herttuala S; Knuuti J; Töyräs J
    BMC Med Imaging; 2019 Jul; 19(1):58. PubMed ID: 31349798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Revascularization on Absolute Myocardial Blood Flow as Assessed by Serial [
    Driessen RS; Danad I; Stuijfzand WJ; Schumacher SP; Knuuti J; Mäki M; Lammertsma AA; van Rossum AC; van Royen N; Raijmakers PG; Knaapen P
    Circ Cardiovasc Imaging; 2018 May; 11(5):e007417. PubMed ID: 29703779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.